Can-Fite Biopharma Ltd Sponsore

Historical 13F Holders

Symbol
CANF
CUSIP
13471N300
All holders as of
Q4 2025
Type
Equity
Class
SPONSORED ADR
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 13471N300 since 12/18/2024, newest first.

Filer % of Class Filed
Orca Capital AG 13G/A Amendment 1 4.1% 4/23/2025
Event 4/22/2025
Orca Capital AG 13G 9.7% 4/16/2025
Event 4/14/2025
Armistice Capital, LLC 13G/A Amendment 2
4.99% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q4 15 597 k $271 k
2025 Q3 16 1.54 M $953 k
2025 Q2 17 905 k $950 k
2025 Q1 15 131 k $194 k
2024 Q4 14 114 k $186 k
2024 Q3 13 754 k $1.52 M
2024 Q2 13 696 k $1.79 M
2024 Q1 11 589 k $1.31 M
2023 Q4 11 290 k $638 k
2023 Q3 10 67.7 k $179 k
2023 Q2 8 54.6 k $168 k
2023 Q1 9 368 k $844 k